Long-Term Effects of Varying Alcohol Dosing in Percutaneous Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Randomized Study With a Follow-up up to 11 Years

2011 ◽  
Vol 27 (6) ◽  
pp. 763-767 ◽  
Author(s):  
Josef Veselka ◽  
Pavol Tomašov ◽  
David Zemánek
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Randomized Study ◽  
Long Term Effects ◽  
Percutaneous Septal Ablation ◽  
Obstructive Hypertrophic Cardiomyopathy

scholarly journals Results of Ten-Year Follow-Up of Alcohol Septal Ablation in Patients with Obstructive Hypertrophic Cardiomyopathy

2018 ◽  
Vol 27 (04) ◽  
pp. 202-207 ◽  
Author(s):  
Anastasiya Rzhannikova ◽  
Sergey Chernyshev ◽  
Lev Kardapoltsev ◽  
Eduard Idov ◽  
Sergey Berdnikov ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Survival Rates ◽  
Rank Test ◽  
Alcohol Septal Ablation ◽  
Term Survival ◽  
Significant Difference ◽  
Obstructive Hypertrophic Cardiomyopathy ◽  
Age And Sex

This study looks at 10-year follow-up outcomes of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy.Between 2000 and 2008, 40 patients with obstructive hypertrophic cardiomyopathy (27 males, 13 females) underwent alcohol septal ablation. The median follow-up period was 123 (2–179) months. The mean age ran to 43.8 + 13.9 years. The initial dose of ethanol (3 mL) was chosen for ablation in all cases.The hospital mortality was 0%. Permanent pacemakers were implanted in 3 of 40 (7.5%) cases in the hospital period. The median clinical follow-up was 123 (2–179) months. Survival rates at 1, 5, 10, and 15 years after the procedure were as follows: 97.5% (95% confidence interval [CI], 95.1–99.9%), 92.5% (95% CI, 94.8–90.2%), 85.0% (95% CI, 82.9–87.1%), and 81.3% (95% CI, 79.3–83.3%), respectively. Seven patients died during follow-up. Sudden death was observed in two cases. Permanent pacemakers were implanted in 2 of 40 (5%) cases in the follow-up. The log-rank test revealed no statistically significant difference between the 15-year survival rate in our cohort and age- and sex-matched general Russian population (p = 0.11113).Alcohol septal ablation provides long-term survival rates that look comparable with age- and sex-matched general population in the 15-year follow-up period.

scholarly journals Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy

2005 ◽  
Vol 46 (3) ◽  
pp. 470-476 ◽  
Author(s):  
Steve R. Ommen ◽  
Barry J. Maron ◽  
Iacopo Olivotto ◽  
Martin S. Maron ◽  
Franco Cecchi ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Long Term Effects ◽  
Septal Myectomy ◽  
Obstructive Hypertrophic Cardiomyopathy

Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy

2016 ◽  
Vol 88 (6) ◽  
pp. 953-960 ◽  
Author(s):  
Silvia Fortunato de Cano ◽  
Manuel Nicolas Cano ◽  
José de Ribamar Costa ◽  
Jairo Alves Pinheiro ◽  
Rodrigo Bellio de Mattos Barretto ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Obstructive Hypertrophic Cardiomyopathy

RF42 LONG TERM RESULTS OF SEPTAL MYECTOMY IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

2018 ◽  
Vol 19 ◽  
pp. e76-00
Author(s):  
G. Saitto ◽  
F. Grimaldi ◽  
A. Varrica ◽  
A. Biondi ◽  
A. Garatti ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Long Term Results ◽  
Septal Myectomy ◽  
Obstructive Hypertrophic Cardiomyopathy
Sign in / Sign up

Export Citation Format

Share Document